Scientific overview of hormone treatment used for rejuvenation

Fertility and Sterility

Volumn 99, Issue 7, 2013, Pages 1807-1813

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DHEA; exercise; growth hormone; testosterone; vitamin D

Indexed keywords

AROMATASE INHIBITOR; GHRELIN; GROWTH HORMONE; MELATONIN; PRASTERONE; PREGNENOLONE; PROTEIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; VITAMIN D;

AGING; BONE DENSITY; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; COGNITION; EXERCISE; HEART FAILURE; HORMONAL THERAPY; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; LIBIDO; LIFE EXPECTANCY; MEMORY; MORTALITY; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; OXIDATIVE STRESS; PENIS ERECTION; PERIPHERAL EDEMA; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN INTAKE; QUALITY OF LIFE; REJUVENATION; REVIEW; STRENGTH; VITAMIN D DEFICIENCY;

AGE FACTORS; AGING; ANABOLIC AGENTS; ANDROGENS; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; EXERCISE; HORMONE REPLACEMENT THERAPY; HORMONES; HUMANS; LIFE STYLE; MALE; REJUVENATION; SUNLIGHT; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84878475761     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.04.009     Document Type: Review

References (139)

1. J.E. Morley A brief history of geriatrics J Geron Biol Sci Med Sci 59 2004 1132 1152
2. M.H. Horani, and J.E. Morley Hormonal fountains of youth Clin Geriatr Med 20 2004 275 292
3. K.T. Khaw, N. Wareham, S. Bingham, A. Welch, R. Luben, and N. Day Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study PLoS Med 5 2008 e12
4. F. Sofi, R. Abbate, G.F. Gensini, and A. Casini Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis Am J Clin Nutr 92 2010 1189 1196
5. M. Yamada, H. Arai, T. Sonoda, and T. Aoyama Community-based exercise program is cost-effective by preventing care and disability in Japanese frail older adults J Am Med Dir Assoc 13 2012 507 511
6. A. Snyder, B. Colvin, and J.K. Gammack Pedometer use increases daily steps and functional status in older adults J Am Med Dir Assoc 12 2011 590 594
7. L.C. Lam, R.C. Chau, B.M. Wong, A.W. Fung, C.W. Tom, and G.T. Leung A 1-year randomized controlled trial comparing mind body exercise (Tai Chi) with stretching and toning exercise on cognitive function in older Chinese adults at risk of cognitive decline J Am Med Dir Assoc 13 2012 568.e15 568.e20
8. T. Valenzuela Efficacy of progressive resistance training interventions in older adults in nursing homes: a systematic review J Am Med Dir Assoc 13 2012 418 428
9. N.A. Singh, S. Quine, L.M. Clemson, E.J. Williams, D.A. Williamson, and T.M. Stavrinos Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled trial J Am Med Dir Assoc 13 2012 24 30
10. L.A. Brienesse, and M.N. Emergson Effects of resistance training for people with Parkinson's disease: a systematic review J Am Med Dir Assoc 14 2013 236 241
11. M.E. Rouge Bugat, P. Cestac, S. Oustric, B. Vellas, and F. Nourhashemi Detecting frailty in primary care: a major challenge for primary care physicians J Am Med Dir Assoc 13 2012 669 672
12. E.O. Hoogendijk, and H.P. van Hout Investigating measurement properties of the Groningen Frailty Indicator: a more systematic approach is needed J Am Med Dir Assoc 13 2012 757 Author reply 757-58
13. L.L. Peters, H. Boter, E. Buskens, and J.P. Slaets Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people J Am Med Dir Assoc 13 2012 546 551
14. J.E. Morley The magic of exercise J Am Med Dir Assoc 9 2008 375 377
15. A.J. Cruz-Jentoft Perspective: protein and exercise for frailty and sarcopenia: still learning J Am Med Dir Assoc 14 2013 69 71
16. C.H. Chou, C.L. Hwang, and Y.T. Wu Effect of exercise on physical function, daily living activities, and quality of life in the frail older adults: a meta-analysis Arch Phys Med Rehabil 93 2012 237 244
17. C.R. Van Wetering, M. Hoogendoorn, R. Broekhuizen, G.J. Geraerts-Kerris, D.R. De Munck, and M.P. Rutten-van Mölken Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial J Am Med Dir Assoc 11 2010 179 187
18. V. Malafarina, F. Uriz-Otano, R. Iniesta, and L. Gil-Guerrero Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review J Am Med Dir Assoc 14 2013 10 17
19. J.E. Morley, J.M. Argiles, W.J. Evans, S. Bhasin, D. Cella, N.E. Deutz Society for Sarcopenia, Cachexia, and Wasting Disease Nutritional recommendations for the management of sarcopenia J Am Med Dir Assoc 11 2010 391 396
20. J.E. Morley Do frail older persons need more protein? J Am Med Dir Assoc 13 2012 667 668
21. M. Tieland, O. van de Rest, M.L. Dirks, N. van der Zwaluw, M. Mensink, and L.J. van Loon Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial J Am Med Dir Assoc 13 2012 720 726
22. M. Tieland, M.L. Dirks, N. van der Zwaluw, L.B. Verdijk, O. van de Rest, and L.C. de Groot Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial J Am Med Dir Assoc 13 2012 713 719
23. F. Mir, F. Zafar, and J.E. Morley Anorexia of aging: can we decrease protein energy undernutrition in the nursing home? J Am Med Dir Assoc 14 2013 77 79
24. F. Neelemaat, J.E. Bosmans, A. Thijs, J.C. Seidell, and M.O. van Bokhorst-de van de Schueren Post-discharge nutritional support in malnourished elderly individuals improves functional limitations J Am Med Dir Assoc 12 2011 295 301
25. J.E. Morley Weight loss in older persons: new therapeutic approaches Curr Pharm Des 13 2007 3637 3647
26. J.E. Morley, E. Chahla, and S. Alkaade Antiaging, longevity and calorie restriction Curr Opin Clin Nutr Metab Care 13 2010 40 45
27. J.E. Morley Undernutrition: a major problem in nursing homes J Am Med Dir Assoc 12 2011 243 246
28. K. Shah, R. Armamento-Villareal, N. Parimi, S. Chode, D.R. Sinacore, and T.N. Hilton Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip BMD induced by weight loss despite decline in bone-active hormones J Bone Miner Res 26 2011 2851 2859
29. H.M. Perry, M. Horowitz, J.E. Morley, P. Patrick, B. Vellas, and R. Baumgartner Longitudinal changes in serum 25-hydroxyvitamin D in older people Metab Clin Exper 48 1999 1028 1032
30. A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, and S.K. Clinton The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know J Clin Endocrinol Metab 96 2011 53 58
31. T. Islam, P. Peiris, R.J. Copeland, M. El Zoghby, and A.N. Peiris Vitamin D: lessons from the veterans population J Am Med Dir Assoc 12 2011 257 262
32. J.D. Mckinney, B.A. Bailey, L.H. Garrett, P. Peiris, T. Manning, and A.N. Peiris Relationship between vitamin D status and ICU outcomes in veterans J Am Med Dir Assoc 12 2011 208 211
33. V.C. Gaddipati, B.A. Bailey, R. Kuriacose, R.J. Copeland, T. Manning, and A.N. Peiris The relationship of vitamin D status to cardiovascular risk factors and amputation risk in veterans with peripheral arterial disease J Am Med Dir Assoc 12 2011 58 61
34. O. Demontiero, M. Herrmann, and G. Duque Supplementation with vitamin D and calcium in long-term care residents J Am Med Dir Assoc 12 2011 190 194
35. J.E. Morley Vitamin D redux J Am Med Dir Assoc 10 2009 591 592
36. J.E. Morley Developing novel therapeutic approaches to frailty Curr Pharm Design 29 2009 3384 3395
37. L. Rejnmark, A. Avenell, T. Masud, F. Anderson, H.E. Meyer, and K.M. Sanders Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials J Clin Endocrinol Metab 97 2012 2670 2681
38. G. Bjelakovic, L.L. Gluud, D. Nikolova, K. Whitfield, J. Wetterslev, and R.G. Simonetti Vitamin D supplementation for prevention of mortality in adults Cochrane Database Syst Rev 2011 CD007470
39. M.L. Melamed, E.D. Michos, W. Post, and B. Astor 25-hydroxyvitamin D levels and the risk of mortality in the general population Arch Intern Med 168 2008 1629 1637
40. M.H. Murad, K.B. Elamin, A. Elnour, M.B. Elamin, A.A. Alkatib, and M.M. Fatourechi Clinical review. The effect of vitamin D on falls: a systematic review and meta-analysis J Clin Endocrinol Metab 96 2011 2997 3006
41. G.J. Bergman, T. Fan, J.T. McFetridge, and S.S. Sen Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis Curr Med Res Opin 26 2010 1193 1201
42. H.A. Bishoff-Ferrari, W.C. Willett, J.B. Wong, A.E. Stuck, H.B. Staehelin, and E.J. Orav Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials Arch Intern Med 169 2009 551 561
43. S. Von Haehling, J.E. Morley, and S.D. Anker From muscle wasting to sarcopenia and myopenia: Update 2012 J Cachexia Sarcopenia Muscle 3 2012 213 217
44. M. Hewison Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl 243 2012 92 102
45. H. Khan, S. Kunutsor, O.H. Franco, and R. Chowdhury Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies Proc Nutr Soc 72 2013 89 97
46. I.J. Riphagen, E. van der Veer, F.A. Muskiet, and M.J. DeJongste Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D Curr Med Res Opin 28 2012 1247 1252
47. K.V. Luong, and L.T. Nguyen The beneficial role of vitamin D in Alzheimer's disease Am J Alzheimers Dis Other Demen 26 2011 511 520
48. C. Wang, E. Nieschlag, R.S. Swerdloff, H. Behre, W.J. Hellstrom, and Gooren ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males Aging Male 12 2009 5 12
49. H.M. Perry 3rd, D.K. Miller, P. Patrick, and J.E. Morley Testosterone and leptin in older African-American men: relationship to age, strength, function, and season Metabolism 49 2000 1085 1091
50. J.E. Morley, P. Patrick, and H.M. Perry 3rd Evaluation of assays available to measure free testosterone Metabolism 51 2002 554 559
51. A. Tajar, I.T. Huhtaniemi, T.W. O'Neill, J.D. Finn, S.R. Pye, and D.M. Lee Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS) J Clin Endocrinol Metab 97 2012 1508 1516
52. A.M. Matsumoto Fundamental aspects of hypogonadism in the aging male Rev Urol 5 Suppl 2003 S3 S10
53. I.T. Huhtaniemi, A. Tajar, D.M. Lee, T.W. O'Neill, J.D. Finn, and G. Bartfai Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men Eur J Endocrinol 166 2012 983 991
54. S. Bhasin, M. Pencina, G.K. Jasuja, T.G. Travison, A. Coviello, and E. Orwoll Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in Framingham Heart Study and applied to three geographically distinct cohorts J Clin Endocrinol Metab 96 2011 2430 2439
55. J.E. Morley, and S. Melmed Gonadal dysfunction in systemic disorders Metabolism 28 1979 1051 1073
56. J.E. Morley Anabolic steroids and frailty J Am Med Dir Assoc 11 2010 533 536
57. Z. Hyde, L. Flicker, O.P. Almeida, G.J. Hankey, K.A. McCaul, and S.A. Chubb Low free testosterone predicts frailty in older men: the health in men study J Clin Endocrinol Metab 95 2010 3165 3172
58. P.M. Cawthon, K.E. Ensrud, G.A. Laughlin, J.A. Cauley, T.T. Dam, and E. Barrett-Connor Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study J Clin Endocrinol Metab 94 2009 3806 3815
59. K.T. Khaw, M. Dowsett, E. Folkerd, S. Bingham, N. Wareham, and R. Luben Endogenous testosterone and mortality due to all causes, cardiovascular disease and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study Circulation 226 2007 2694 2701
60. L.A. Cummings-Vaughn, T.K. Malmstrom, J.E. Morley, and D.K. Miller Testosterone is not associated with mortality in older African-American males Aging Male 14 2011 132 140
61. G.A. Laughlin, E. Barrett-Connor, and J. Bergstrom Low serum testosterone and mortality in older men J Clin Endocrinol Metab 93 2008 68 75
62. J.E. Morley, F.E. Kaiser, H.M. Perry III, P. Patrick, P.M.K. Morley, and P.M. Stauber Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men Metabolism 46 1997 410 413
63. M.M. Shores, N.L. Smith, C.W. Forsberg, B.D. Anawalt, and A.M. Matsumoto Testosterone treatment and mortality in men with low testosterone levels J Clin Endocrinol Metab 97 2012 2050 2058
64. M. Cesari, and B. Vellas Saropcenia: a novel clinical condition or still a matter for research? J Am Med Dir Assoc 13 2012 766 767
65. F. Landi, R. Liperoti, D. Fusco, S. Mastropaolo, D. Quattrociocchi, and A. Proia Sarcopenia and mortality among older nursing home residents J Am Med Dir Assoc 13 2012 121 126
66. J.E. Morley, A.M. Abbatecola, J.M. Argiles, V. Baracos, J. Bauer, S. Bhasin Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop Sarcopenia with limited mobility: an international consensus J Am Med Dir Assoc 12 2011 403 409
67. R.A. Fielding, B. Vellas, W.J. Evans, S. Bhasin, J.E. Morley, and A.B. Newman Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia J Am Med Dir Assoc 12 2011 249 256
68. J.M. Bauer, M.J. Kaiser, and C.C. Sieber Sarcopenia in nursing home residents J Am Med Dir Assoc 9 2008 545 551
69. Y. Rolland, S. Czerwinski, G. Abellan van Kan, J.E. Morley, M. Cesari, and G. Onder Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives J Nutr Health Aging 12 2008 433 450
70. R.N. Baumgartner, D.L. Waters, D. Gallagher, J.E. Morley, and P.J. Garry Predictors of skeletal muscle mass in elderly men and women Mech Ageing Dev 107 1999 123 136
71. G.A. Wittert, I.M. Chapman, M.T. Haren, S. Mackintosh, P. Coates, and J.E. Morley Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status J Gerontol A Biol Sci Med Sci 58 2003 618 625
72. S.T. Page, J.K. Amory, F.D. Bowman, B.D. Anawalt, A.M. Matsumoto, and W.J. Bremner Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T J Clin Endocrinol Metab 90 2005 1502 1510
73. S. Bhasin, L. Woodhouse, R. Casaburi, A.B. Singh, R.P. Mac, and M. Lee Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle J Clin Endocrinol Metab 90 2005 678 688
74. S. Basaria, A.D. Coviello, T.G. Travison, T.W. Storer, W.R. Farwell, and A.M. Jette Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
75. U. Srivinas-Shanker, S.A. Roberts, M.J. Connelly, M.D. O'Connell, J.E. Adams, and J.A. Oldham Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2010 639 650
76. A.M. Kenny, A. Kleppinger, K. Annis, M. Rathier, B. Browner, and J.O. Judge Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty J Am Geriatr Soc 58 2010 1134 1143
77. F. Iellamo, M. Volterrani, G. Caminiti, R. Karam, R. Massaro, and M. Fini Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study J Am Coll Cardiol 56 2010 1310 1316
78. G. Caminiti, M. Volterrani, F. Iellamo, G. Marazzi, R. Massaro, and M. Miceli Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study J Am Coll Cardiol 54 2009 919 927
79. I.M. Chapman, R. Misvanathan, A.J. Hammond, J.E. Morley, J.B. Field, and K. Tai Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women Am J Clin Nutr 89 2009 880 889
80. T.G. Travison, J.E. Morley, A.B. Araujo, A.B. O'Donnell, and J.B. McKinlay The relationship between libido and testosterone levels in aging men J Clin Endocrinol Metab 91 2006 2509 2513
81. S.H. Tariq, M.T. Haren, M.J. Kim, and J.E. Morley Andropause: is the emperor wearing any clothes? Rev Endocr Metab Disord 6 2005 77 84
82. M. Spitzer, S. Basaria, T.G. Travison, M.N. Davda, A. Paley, and B. Cohen Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial Ann Intern Med 157 2012 681 691
83. A.M. Traish, M.M. Miner, A. Morgentaler, and M. Zitzmann Testosterone deficiency Am J Med 124 2011 578 587
84. J.E. Morley Androgens and aging Maturitas 38 2011 61 71
85. D. Mellström, O. Johnell, O. Ljunggren, A.L. Eriksson, M. Lorentzon, and H. Mallmin Free testosterone is an independent predictor of MBD and prevalent fractures in elderly men: MrOS Sweden J Bone Miner Res 21 2006 529 535
86. J.K. Amory, N.B. Watts, K.A. Easley, P.R. Sutton, B.D. Anawalt, and A.M. Matsumoto Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone J Clin Endocrinol Metab 89 2004 503 510
87. J.E. Morley, F. Kaiser, W.J. Raum, H.M. Perry 3rd, J.F. Flood, and J. Jensen Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone Proc Natl Acad Sci USA 94 1997 7537 7542
88. L.W. Chu, S. Tam, P.W. Lee, R.L. Wong, P.Y. Yik, and W. Tsui Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men Clin Endocrinol (Oxf) 68 2008 589 598
89. L.W. Chu, S. Tam, R.L. Wong, P.Y. Yik, Y. Song, and B.M. Cheung Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men J Alzheimers Dis 21 2010 1335 1345
90. J.E. Morley, S.A. Farr, V.B. Kumar, and H.J. Armbrecht The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease Curr Pharm Des 18 2012 1123 1130
91. S.A. Farr, T.O. Price, and W.A. Banks Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice J Alzheimers Dis 32 2012 447 455
92. V.B. Kumar, S.A. Farr, J.F. Flood, V. Kamlesh, M. Franko, and W.A. Banks Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice Peptides 21 2000 1769 1775
93. J.F. Flood, S.A. Farr, F.E. Kaiser, M. La Regina, and J.E. Morley Age-related decrease of plasma testosterone in SAMP8 mice - replacement improves age-related impairment of learning and memory Physiol Beh 57 1995 669 673
94. M.M. Cherrier Testosterone effects on cognition in health and disease Front Horm Res 37 2009 150 162
95. R.R. Hajjar, F.E. Kaiser, and J.E. Morley Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis J Clin Endocrinol Metab 82 1997 3793 3796
96. E.J. Chahla, M.E. Hayek, and J.E. Morley Testosterone replacement therapy and cardiovascular risk factors modification Aging Male 14 2011 83 90
97. O.M. Calof, A.B. Singh, M.L. Lee, A.M. Kenny, R.J. Urban, and J.L. Tenover Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J Gerontol A Biol Sci Med Sci 60 2005 1451 1457
98. J.E. Morley, H.M. Perry 3rd, R.T. Kevorkian, and P. Patrick Comparison of screening questionnaires for the diagnosis of hypogonadism Maturitas 53 2006 424 429
99. J.E. Morley Should frailty be treated with testosterone? Aging Male 14 2011 1 3
100. R. Haring, V. Xanthakis, A. Coviello, L. Sullivan, S. Bhasin, and H. Wallaschofski Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: The Framingham Heart Study Int J Androl 35 2012 775 782
101. A. Tsujimura, K. Matsumiya, T. Takao, Y. Miyagawa, S. Takada, and M. Koga Treatment with human chorionic gonadotropin for PADAM: a preliminary report Aging Male 8 2005 175 179
102. S.A. Burnett-Bowie, E.A. McKay, H. Lee, and B.Z. Leder Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels J Clin Endocrniol Metab 94 2009 4785 4792
103. S.M. Harman, and M.R. Blackman The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men Horm Res 60 Suppl 1 2003 121 124
104. R.M. Goel, and A.R. Cappola Dehydroepiandrosterone sulfate and postmenopausal women Curr Opin Endocrinol Diabetes Obes 18 2011 171 176
105. W. Regelson, and C. Colman The superhormone promise: nature's antidote to aging 1997 Pocket Books New York
106. E.E. Baulieu, G. Thomas, S. Legrain, N. Lahlou, M. Roger, and B. Debuire Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue Proc Natl Acad Sci USA 97 2000 4279 4284
107. G. Percheron, J.Y. Hogrel, S. Denot-Ledunois, G. Fayet, F. Forette, and E.E. Baulieu Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial Arch Intern Med 163 2003 720 727
108. W.L. Baker, S. Karan, and A.M. Kenny Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review J Am Geriatr Soc 59 2011 997 1002
109. D. Von Muhlen, G.A. Laughlin, D. Kritz-Silverstein, J. Bergstrom, and R. Bettencourt Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial Osteoporos Int 19 2008 699 707
110. E.P. Weiss, K. Shah, L. Fontana, C. Lambert, J.O. Holloszy, and D.T. Villareal Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone Am J Clin Nutr 89 2009 1459 1467
111. J.F. Flood, J.E. Morley, and E. Roberts Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive Proc Natl Acad Sci USA 92 1995 10806 10810
112. D. Kritz-Silverstein, D. von Muhlen, G.A. Laughlin, and R. Bettencourt Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) trial J Am Geriatr Soc 56 2008 1292 1298
113. J.K. Van Niekerk, F.A. Huppert, and J. Herbert Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation Psychoneuroendocrinology 26 2001 591 612
114. J. Grimley Evans, R. Malouf, F. Huppert, and J.K. van Niekerk Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people Cochrane Database Syst Rev 2006 CD006221
115. K.T. Barnhart, E. Freeman, J.A. Grisso, D.J. Rader, M. Sammel, and S. Kapoor The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health related quality of life J Clin Endocrinol Metab 84 1999 3896 3902
116. A. Finckh, J.C. Berner, B. Aubry-Rozier, and A.K. So A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia J Rheumatol 32 2005 1336 1340
117. W. Arlt, F. Callies, and B. Allolio DHEA replacement in women with adrenalin sufficiency - pharmacokinetics bioconversion and clinical effects on well-being, sexuality and cognition Endocr Res 26 2000 505 511
118. E.C. Hersch, and G.R. Merriam Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus? Clin Interv Aging 3 2008 121 129
119. J.D. Veldhuis Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women Ageing Res Rev 7 2008 189 208
120. D. Rudman, A.G. Feller, H.S. Nagraj, G.A. Gergans, P.Y. Lalitha, and A.F. Goldberg Effects of human growth hormone in men over 60 years old N Engl J Med 323 1990 1 6
121. L. Cohn, A.G. Feller, M.W. Draper, I.W. Rudman, and D. Rudman Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-1 concentrations Clin Endocrniol (Oxf) 39 1993 417 425
122. F.E. Kaiser, A.J. Silver, and J.E. Morley The effect of recombinant human growth hormone on malnourished older individuals J Am Geriatr Soc 39 1991 235 240
123. R.J. Urban Growth hormone and testosterone: anabolic effects on muscle Horm Res Paediatr 76 Suppl 1 2011 81 83
124. F.R. Sattler, C. Castaneda-Sceppa, E.F. Binder, E.T. Schroeder, Y. Wang, and S. Bhasin Testosterone and growth hormone improve body composition and muscle performance in older men J Clin Endocrinol Metab 94 2009 1991 2001
125. G. Fanciulli, A. Delitala, and G. Delitala Growth hormone, menopause and ageing: no definite evidence for "rejuvenation" with growth hormone Hum Reprod Update 15 2009 341 358
126. V.E. Chaves, F.M. Junior, and G.L. Bertolini The metabolic effects of growth hormone in adipose tissue Endocrine 2013
127. H. Liu, D.M. Bravata, I. Olkin, S. Nayak, B. Roberts, and A.M. Garber Systematic review: the safety and efficacy of growth hormone in the health elderly Ann Intern Med 146 2007 104 115
128. M.R. Blackman, J.D. Sorkin, T. Munzer, M.F. Bellantoni, J. Busby-Whitehead, and T.E. Stevens Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial JAMA 288 2002 2282 2292
129. D.D. Taub, W.J. Murphy, and D.L. Longo Rejuvenation of the aging thymus: growth hormone- and ghrelin-mediated signaling pathways Curr Opin Pharmacol 10 2010 408 424
130. W.A. Banks, J.E. Morley, S.A. Farr, T.O. Price, N. Ercal, and I. Vidaurre Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice Proc Natl Acad Sci USA 107 2010 22272 22277
131. F.S. Gaskin, S.A. Farr, W.A. Banks, V.B. Kumar, and J.E. Morley Ghrelin-induced feeding is dependent on nitric oxide Peptides 24 2003 913 918
132. F. Strasser Clinical application of ghrelin Curr Pharm Des 18 2012 4800 4812
133. H.K. White, C.D. Petrie, W. Landschulz, D. MacLean, A. Taylor, and K. Lyles Effects of an oral growth hormone secretagogue in older adults J Clin Endocrinol Metab 94 2009 1198 1206
134. R. Nass, S.S. Pezzoli, M.C. Oliveri, J.T. Patrie, F.E. Harrell, and J.L. Clasey Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial Ann Intern Med 149 2008 601 611
135. A. Adunsky, J. Chandler, N. Heyden, J. Lutkiewicz, B.B. Scott, and Berdy MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study Arch Gerontol Geriatr 53 2011 183 189
136. G.A. Bubenik, and S.J. Konturek Melatonin and aging: prospects for human treatment J Physiol Pharmacol 62 2011 13 19
137. I.M. van Geijlswijk, H.P. Korsilius, and M.G. Smits The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis Sleep 33 2010 1605 1614
138. S.A. Ferguson, S.M. Rajaratnam, and D. Dawson Melatonin agonists and insomnia Expert Rev Neurother 10 2010 305 318
139. M.J. Kim, and J.E. Morley The hormonal fountains of youth: myth or reality? J Endocrinol Invest 28 11 Suppl Proc 2005 5 14